ALC logo

Alcon Inc. Stock Price

SWX:ALC Community·CHF 31.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 32 Fair Values set on narratives written by author

ALC Share Price Performance

CHF 62.80
-17.74 (-22.03%)
CHF 75.68
Fair Value
CHF 62.80
-17.74 (-22.03%)
17.0% undervalued intrinsic discount
CHF 75.68
Fair Value
Price CHF 62.80
AnalystConsensusTarget CHF 75.68
AnalystLowTarget CHF 58.49
AnalystHighTarget CHF 93.18

ALC Community Narratives

AnalystConsensusTarget·
Fair Value CHF 75.68 17.0% undervalued intrinsic discount

Cutting Edge Eye Care Solutions Will Transform Outcomes For Global Aging Populations

0users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
AnalystLowTarget·
Fair Value CHF 58.49 7.4% overvalued intrinsic discount

Government Price Cuts Will Compress Margins Though Telemedicine Supports

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value CHF 93.18 32.6% undervalued intrinsic discount

Unity VCS And LumiThera Will Drive Global Eye Care Transformation

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
CHF 58.49
7.4% overvalued intrinsic discount
Revenue
6.61% p.a.
Profit Margin
8.64%
Future PE
38.9x
Price in 2029
CHF 67.29
CHF 93.18
32.6% undervalued intrinsic discount
Revenue
7.71% p.a.
Profit Margin
13.84%
Future PE
37.17x
Price in 2029
CHF 107.22

Trending Discussion

Updated Narratives

ALC logo

ALC: Future Contact Lens Launches Will Balance Margin Pressure Risks

Fair Value: CHF 58.49 7.4% overvalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ALC logo

ALC: Weekly Lens Launch And Buybacks Will Support Future Share Outperformance

Fair Value: CHF 75.68 17.0% undervalued intrinsic discount
19 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ALC logo

ALC: Ongoing Share Repurchases And Higher Future P/E Will Support Upside

Fair Value: CHF 93.18 32.6% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and good value.

0 Risks
3 Rewards

Alcon Inc. Key Details

US$10.4b

Revenue

US$4.6b

Cost of Revenue

US$5.8b

Gross Profit

US$4.8b

Other Expenses

US$980.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 06, 2026
2.01
55.67%
9.42%
21.5%
View Full Analysis

About ALC

Founded
1945
Employees
25942
CEO
David Endicott
WebsiteView website
www.alcon.com

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Recent ALC News & Updates

Recent updates

No updates